Coherus Oncology, Inc. (CHRS) SEC filings
CHRS SEC filings moved a median of -0.77% by the close. CHRS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CHRS overview →
89 measured CHRS SEC filing events.
Where these CHRS SEC filings landedvs 89 measured CHRS SEC filing reactions
| Middle 50% of CHRS SEC filing reactions | -4.06% to +2.78% |
|---|---|
| Median reaction (to close) | -0.77% |
| Measured reactions | 89 |
Point-in-time · zero look-ahead
Half of the 89 CHRS SEC filing events with a measured close landed between -4.06% and +2.78%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Coherus Oncology, Inc. For: Aug 28 | SEC filing · Form 8-K | +0.72% | -2.88% | |
| Form 8-K Coherus Oncology, Inc. For: Aug 17 | SEC filing · Form 8-K | -0.40% | +6.35% | |
| Form 10-Q Coherus Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.99% | -8.33% | |
| Form 8-K Coherus Oncology, Inc. For: Aug 05 | SEC filing · Form 8-K | +3.99% | -8.33% | |
| Form S-8 Coherus Oncology, Inc. | SEC filing · Form S-8 | +3.99% | -8.33% | |
| Form 8-K Coherus Oncology, Inc. For: Jun 12 | SEC filing · Form 8-K | +1.09% | +0.73% | |
| Form 8-K Coherus Oncology, Inc. For: May 27 | SEC filing · Form 8-K | +0.31% | -1.88% | |
| Form DEFA14A Coherus Oncology, Inc. | SEC filing · Form DEFA14A | +0.58% | +0.00% | |
| Form 10-Q Coherus Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.51% | -2.29% | |
| Form 8-K Coherus Oncology, Inc. For: May 11 | SEC filing · Form 8-K | +0.51% | -2.29% | |
| Form DEFA14A Coherus Oncology, Inc. | SEC filing · Form DEFA14A | +1.10% | -3.31% | |
| Form ARS Coherus Oncology, Inc. For: Dec 31 | SEC filing · Form ARS | +0.26% | +1.53% | |
| Form DEF 14A Coherus Oncology, Inc. For: May 27 | SEC filing · Form DEF | +0.26% | +1.53% | |
| Form DEFA14A Coherus Oncology, Inc. | SEC filing · Form DEFA14A | -0.84% | +5.03% | |
| Form PRE 14A Coherus Oncology, Inc. For: May 27 | SEC filing · Form PRE | +0.00% | +2.44% | |
| Form 10-K Coherus Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.54% | +4.84% | |
| Form 8-K Coherus Oncology, Inc. For: Mar 09 | SEC filing · Form 8-K | +0.54% | +4.84% | |
| Form 8-K Coherus Oncology, Inc. For: Feb 12 | SEC filing · Form 8-K | -1.24% | +0.62% | |
| Form 8-K Coherus Oncology, Inc. For: Feb 04 | SEC filing · Form 8-K | +5.04% | -2.63% | |
| Form 8-K Coherus Oncology, Inc. For: Jan 23 | SEC filing · Form 8-K | +3.91% | +12.87% | |
| Form 8-K Coherus Oncology, Inc. For: Jan 13 | SEC filing · Form 8-K | +0.30% | +2.41% | |
| Form EFFECT Coherus Oncology, Inc. | SEC filing · Form EFFECT | +1.15% | -0.77% | |
| Form 10-Q Coherus Oncology, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.74% | -0.74% | |
| Form 8-K Coherus Oncology, Inc. For: Nov 06 | SEC filing · Form 8-K | -0.74% | -0.74% | |
| Form 8-K Coherus Oncology, Inc. For: Sep 05 | SEC filing · Form 8-K | +0.00% | +3.79% | |
| Form 10-Q Coherus Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.95% | -6.08% | |
| Form 8-K Coherus Oncology, Inc. For: Aug 07 | SEC filing · Form 8-K | +1.95% | -6.08% | |
| Form 8-K Coherus Oncology, Inc. For: Jun 30 | SEC filing · Form 8-K | +0.30% | -3.73% | |
| Form 8-K Coherus Oncology, Inc. For: Jun 11 | SEC filing · Form 8-K | -1.72% | +4.17% | |
| Form 8-K Coherus Oncology, Inc. For: May 29 | SEC filing · Form 8-K | +0.39% | -1.29% | |
| Form 10-Q Coherus BioSciences, For: Mar 31 | SEC filing · Form 10-Q | +1.72% | -4.06% | |
| Form 8-K Coherus BioSciences, For: May 12 | SEC filing · Form 8-K | +1.72% | -4.06% | |
| Form ARS Coherus BioSciences, For: Dec 31 | SEC filing · Form ARS | -0.30% | +5.85% | |
| Form DEF 14A Coherus BioSciences, For: Jun 11 | SEC filing · Form DEF | -0.30% | +5.85% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | -0.30% | +5.85% | |
| Form 8-K Coherus BioSciences, For: Apr 22 | SEC filing · Form 8-K | +0.90% | +0.98% | |
| Form 8-K Coherus BioSciences, For: Apr 16 | SEC filing · Form 8-K | -0.13% | -0.89% | |
| Form 8-K Coherus BioSciences, For: Apr 11 | SEC filing · Form 8-K | +7.48% | +12.64% | |
| Form 8-K Coherus BioSciences, For: Mar 31 | SEC filing · Form 8-K | +0.21% | +15.31% | |
| Form 10-K Coherus BioSciences, For: Dec 31 | SEC filing · Form 10-K | -2.54% | -4.57% | |
| Form 8-K Coherus BioSciences, For: Mar 11 | SEC filing · Form 8-K | +0.01% | -10.04% | |
| Form 8-K Coherus BioSciences, For: Mar 10 | SEC filing · Form 8-K | -0.48% | +1.94% | |
| Form 8-K Coherus BioSciences, For: Mar 04 | SEC filing · Form 8-K | -1.95% | +5.00% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | -1.95% | +5.00% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | +2.44% | +9.76% | |
| Form DEFM14A Coherus BioSciences, | SEC filing · Form DEFM14A | +0.45% | +8.93% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | +2.38% | -2.04% | |
| Form PREM14A Coherus BioSciences, For: Jan 10 | SEC filing · Form PREM14A | +2.67% | -2.67% | |
| Form 8-K Coherus BioSciences, For: Jan 13 | SEC filing · Form 8-K | +2.38% | -2.04% | |
| Form 8-K Coherus BioSciences, For: Nov 27 | SEC filing · Form 8-K | -5.00% | -16.11% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | +0.82% | -6.04% | |
| Form 8-K Coherus BioSciences, For: Dec 02 | SEC filing · Form 8-K | -3.87% | -17.39% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | -3.87% | -17.39% | |
| Form 10-Q Coherus BioSciences, For: Sep 30 | SEC filing · Form 10-Q | +4.13% | +3.03% | |
| Form 8-K Coherus BioSciences, For: Nov 06 | SEC filing · Form 8-K | +4.13% | +3.03% | |
| Form 8-K Coherus BioSciences, For: Sep 13 | SEC filing · Form 8-K | -9.09% | -20.45% | |
| Form 10-Q Coherus BioSciences, For: Jun 30 | SEC filing · Form 10-Q | +0.69% | -1.38% | |
| Form 8-K Coherus BioSciences, For: Aug 07 | SEC filing · Form 8-K | +0.69% | -1.38% | |
| Form S-8 Coherus BioSciences, | SEC filing · Form S-8 | +0.69% | -1.38% | |
| Form 8-K Coherus BioSciences, For: Jun 27 | SEC filing · Form 8-K | +0.31% | -12.58% | |
| Form 8-K Coherus BioSciences, For: Jun 26 | SEC filing · Form 8-K | +1.18% | +0.00% | |
| Form 8-K Coherus BioSciences, For: May 31 | SEC filing · Form 8-K | -1.69% | +0.56% | |
| Form 8-K Coherus BioSciences, For: May 29 | SEC filing · Form 8-K | -1.69% | +0.56% | |
| Form 8-K/A Coherus BioSciences, For: May 08 | SEC filing · Form 8-K | +0.00% | +0.96% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | +4.90% | +1.96% | |
| Form 10-Q Coherus BioSciences, For: Mar 31 | SEC filing · Form 10-Q | -8.76% | -12.44% | |
| Form 8-K Coherus BioSciences, For: May 08 | SEC filing · Form 8-K | +0.00% | -5.78% | |
| Form 8-K Coherus BioSciences, For: May 09 | SEC filing · Form 8-K | -8.76% | -12.44% | |
| Form ARS Coherus BioSciences, For: Dec 31 | SEC filing · Form ARS | -1.36% | -2.27% | |
| Form DEF 14A Coherus BioSciences, For: May 29 | SEC filing · Form DEF | -1.36% | -2.27% | |
| Form DEFA14A Coherus BioSciences, | SEC filing · Form DEFA14A | -1.36% | -2.27% | |
| Form S-8 Coherus BioSciences, | SEC filing · Form S-8 | -0.84% | +0.84% | |
| Form 10-K Coherus BioSciences, For: Dec 31 | SEC filing · Form 10-K | -0.68% | +0.00% | |
| Form 8-K Coherus BioSciences, For: Mar 13 | SEC filing · Form 8-K | +10.95% | +3.33% | |
| Form 8-K Coherus BioSciences, For: Mar 01 | SEC filing · Form 8-K | -6.69% | -10.63% | |
| Form 8-K Coherus BioSciences, For: Feb 20 | SEC filing · Form 8-K | -3.00% | +3.20% | |
| Form 8-K Coherus BioSciences, For: Feb 05 | SEC filing · Form 8-K | +0.93% | +1.51% | |
| Form 8-K Coherus BioSciences, For: Jan 19 | SEC filing · Form 8-K | +1.14% | -5.15% | |
| Form 8-K Coherus BioSciences, For: Jan 10 | SEC filing · Form 8-K | -2.18% | -4.03% | |
| Form 8-K Coherus BioSciences, For: Dec 26 | SEC filing · Form 8-K | -11.00% | -10.33% | |
| Form 8-K Coherus BioSciences, For: Dec 09 | SEC filing · Form 8-K | -3.32% | -1.88% | |
| Form 8-K Coherus BioSciences, For: Dec 07 | SEC filing · Form 8-K | -2.08% | +2.78% | |
| Form 8-K Coherus BioSciences, For: Nov 27 | SEC filing · Form 8-K | -0.52% | +10.47% | |
| Form 8-K/A Coherus BioSciences, For: Sep 08 | SEC filing · Form 8-K | -2.17% | +6.83% | |
| Form 10-Q Coherus BioSciences, For: Sep 30 | SEC filing · Form 10-Q | -7.59% | -8.52% | |
| Form 8-K Coherus BioSciences, For: Nov 06 | SEC filing · Form 8-K | -7.59% | -8.52% | |
| Form 8-K/A Coherus BioSciences, For: Sep 08 | SEC filing · Form 8-K | -1.09% | -3.28% | |
| Form 8-K Coherus BioSciences, For: Oct 24 | SEC filing · Form 8-K | -3.96% | -0.66% | |
| Form 8-K Coherus BioSciences, For: Oct 27 | SEC filing · Form 8-K | -3.96% | -0.66% |
Keep exploring
More CHRS: earnings → · analyst actions → · CHRS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF) | 278 | -0.48% | 36% |
| AtriCure, Inc. (ATRC) | 276 | +0.04% | 51% |
| Xenon Pharmaceuticals Inc. - Common Shares (XENE) | 276 | +0.03% | 50% |
| Aclaris Therapeutics, Inc. (ACRS) | 275 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.